MedCity News January 15, 2026
Naomi Fried

This year will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here four predictions.

The rise of AI has powered a wave of interest in digital innovation within pharma. But to have a lasting impact, AI — like any innovation in digital health — must be able to deliver value by being easily absorbed into pharma’s everyday workflow.

I believe that 2026 will be the turning point from AI “hype” to the adoption of meaningful AI and digital health solutions in pharma. Here are my predictions:

1. Pharma leans into greater efficiency

Pharma’s focus in 2026 will be on efficiency. Facing uncertainty about the future of pricing and...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
Related Articles:
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat
Biotech investor Cormorant secures $150M for another SPAC deal
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety
Introducing the Sunday Times Tech 100: Life sciences part 1

Share Article